Drug delivery systems for the treatment of sensorineural hearing loss

Acta Oto-Laryngologica

Volumn 127, Issue SUPPL. 557, 2007, Pages 30-35

  Nakagawa, Takayuki ^a   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biodegradable material; Drug delivery; Hearing loss; Inner ear; Topical application

Indexed keywords

AMINOGLYCOSIDE; BECLOMETASONE; BETAMETHASONE SODIUM PHOSPHATE; BIOPOLYMER; BRAIN DERIVED NEUROTROPHIC FACTOR; GELATIN; GENTAMICIN; POLYGLACTIN; SILOXANE; SOMATOMEDIN; STEROID; BIOMATERIAL; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; COCHLEA; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; EARDRUM; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TOPICAL TREATMENT; TRANSDERMAL PATCH; VERTIGO; DELAYED RELEASE FORMULATION; HUMAN; HYDROGEL; INSTRUMENTATION; REVIEW; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; BIOCOMPATIBLE MATERIALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HEARING LOSS, SENSORINEURAL; HUMANS; HYDROGEL; LACTIC ACID; POLYGLYCOLIC ACID; POLYMERS; SILOXANES;

EID: 33947327367     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/03655230601065332     Document Type: Article

References (40)

1. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997;15:631-43.
2. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 2002;99:1657-60.
3. Nakagawa T, Kim TS, Murai N, Endo T, Iguchi F, Tateya I, et al. A novel technique for inducing local inner ear damage. Hear Res 2003;176:122-7.
4. Cunningham LL, Cheng AG, Rubel EW. Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 2002;22:8532-40.
5. Duan ML, Ulfendahl M, Laurell G, Counter AS, Pyykko I, Borg E, et al. Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear Res 2002;169:169-78.
6. Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003;23:4395-400.
7. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005;11:271-6.
8. Maeda Y, Fukushima K, Nishizaki K, Smith RJ. In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet 2005;14:1641-50.
9. Juhn SK, Rybak LP. Labyrinthine barriers and cochlear homeostasis. Acta Otolaryngol (Stockh) 1981;91:529-34.
10. Ersner MS. Transtympanic injection of anesthetics for the treatment of Menière's Syndrome. Arch Otorhinolaryngol 1951;43-52.
11. Vö lger G. Beseitigung von Labyrinthliquordruckstö rungen bei dem Menièrschen Symptomkomplex durch das Hyaluronidasepräparat Kinetin. HNO 1952;3:142-7.
12. Schuknecht HF. Ablation therapy for the relief of Meniere's disease. Laryngoscope 1956;66:859-70.
13. Salt AN, Plontke KR. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005;10:1299-306.
14. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114:102-5.
15. Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000;257:362-5.
16. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001;124:203-7.
17. Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813-23.
18. Staecker H, Li D, O'Malley BW Jr, Van De Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol (Stockh) 2001;121:157-63.
19. Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001;12:773-81.
20. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects SGNs from ototoxic damage. Audiol Neurootol 2004;9:135-43.
21. Hakuba N, Watabe K, Hyodo J, Ohashi T, Eto Y, Taniguchi M, et al. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther 2003;10:426-33.
22. Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, et al. Guinea pig auditory neurons are protected by glial cell line-derived neurotrophic factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
23. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol (Stockh) 2002;122:698-702.
24. Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stover T. Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 2003;24:222-7.
25. Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 2004;11:1205-14.
26. Arnold W, Senn P, Hennig M, Michaelis C, Deingruber K, Scheler R, et al. Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurotol 2005;10:53-63.
27. Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005;115:2000-5.
28. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, et al. A novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005;115:2016-20.
29. Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim TS, et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006;116:529-33.
30. Colas A. Silicones in pharmaceutical applications. Dow-Corning Healthcare Industries. http://www.dowcorning.com/content/publishedlit/51-993a-01.pdf
31. Ishihara T, Izumo N, Higaki M, Shimada E, Hagi T, Mine L, et al. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile. J Control Release 2005;105:68-76.
32. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005;109:256-74.
33. Okada H, Yamamoto M, Heya Y, Inoue Y, Kamei S, Ogawa Y, et al. Drug delivery using biodegradable microspheres. J Control Release 1994;28:121-9.
34. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release 1993;25:89-98.
35. Higaki M, Ishihara T, Izumo N, Takatsu M, Mizushima Y. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis 2005;64:1132-6.
36. Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, et al. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res 2006;82:657-63.
37. Husmann KR, Morgan AS, Girod DA, Durham D. Round window administration of gentamicin: a new method for the study of ototoxicity of cochlear hair cells. Hear Res 1998;125:109-19.
38. Hatano T, Miyamoto S, Kawakami O, Yamada K, Hashimoto N, Tabata Y. Acceleration of aneurysm healing by controlled release of basic fibroblast growth factor with the use of polyethylene terephthalate fiber coils coated with gelatin hydrogel. Neurosurgery 2003;53:393-400.
39. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005;26:7095-103.
40. Alzamil KS, Linthicum FH Jr. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000;109:30-2.